Page 21 - மரபியல் நிறுவனம் ஆஃப் தி நோவர்த்திச் ஆராய்ச்சி அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மரபியல் நிறுவனம் ஆஃப் தி நோவர்த்திச் ஆராய்ச்சி அடித்தளம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மரபியல் நிறுவனம் ஆஃப் தி நோவர்த்திச் ஆராய்ச்சி அடித்தளம் Today - Breaking & Trending Today

Religious beliefs modulate protein expression linked to cardiovascular disease in US South Asians


Religious beliefs modulate protein expression linked to cardiovascular disease in US South Asians
The Study on Stress, Spirituality and Health (SSSH), a cutting-edge proteomics analysis, suggests that religious beliefs modulate protein expression associated with cardiovascular disease in South Asians in the United States. The research, published by investigators from Massachusetts General Hospital (MGH) and Beth Israel Deaconess Medical Center (BIDMC) and the University of California San Francisco (UCSF) in
Scientific Reports, demonstrates that spiritual struggles, in particular, significantly modify the impact of unique proteins on risk of developing cardiovascular disease (CVD) in U.S. South Asians, a community that has especially high rates of CVD. ....

United States , Towia Libermann , Emily Henderson , Medicine At Harvard Medical School , Center On Genomics , Beth Israel Deaconess Medical Center , Health Disparities , Systems Biology Center , Mongan Institute , University Of California San Francisco , South Asians , Massachusetts General Hospital , California San Francisco , Scientific Reports , Alexandra Shields , Vulnerable Populations , Harvard Medical School , South Asians Living , San Francisco Bay Area , General Medicine , Cardiovascular Disease , Medical School , Protein Expression , ஒன்றுபட்டது மாநிலங்களில் , எமிலி ஹென்டர்சன் , மருந்து இல் ஹார்வர்ட் மருத்துவ பள்ளி ,

Study reveals significant role of ADAMTS1 protein in uveal melanoma


Study reveals significant role of ADAMTS1 protein in uveal melanoma
Scientists from the University of Granada and GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), in a study led by Juan Carlos Rodríguez-Manzaneque, have demonstrated the significant role of a protein called ADAMTS1 in uveal melanoma, one of the rarest and most aggressive cancers that exist, which develops in the eye.
tumors are composed not only of a mass of cells that grow uncontrollably but also of the environment they create during their growth together creating what is known as the tumor microenvironment . Within this environment, there are proteins that remodel it, known as extracellular proteases, which are capable of inhibiting or contributing to tumor growth and metastasis. They do this by modifying non-cellular elements of the tumor microenvironment that form the so-called extracellular matrix. ....

Juan Carlos Rodr , Emmanuelle Charpentier , Jennifera Doudna , Emily Henderson , Andalusian Government Centre For Genomics , Us National Cancer Institute , University Of Granada , Oncological Research , Granada Andalusian Government Centre , Nobel Prize , Cancer Genome Atlas Project , Cancer Institute , இம்மானுவேல் சார்பென்டிர் , எமிலி ஹென்டர்சன் , அண்டலூசின் அரசு மையம் க்கு மரபியல் , எங்களுக்கு தேசிய புற்றுநோய் நிறுவனம் , பல்கலைக்கழகம் ஆஃப் க்ரெநாட , க்ரெநாட அண்டலூசின் அரசு மையம் , நோபல் ப்ரைஸ் , புற்றுநோய் மரபணு அட்லஸ் ப்ராஜெக்ட் , புற்றுநோய் நிறுவனம் ,

Study offers a differentiated patient-specific solution in minimal residual disease testing


Study offers a differentiated patient-specific solution in minimal residual disease testing
Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. This compelling and technically distinct approach will help expand Exact Sciences leadership in precision oncology and offers a differentiated patient-specific solution in minimal residual disease testing.
Analysis of DNA shed into a patient s blood stream can provide a noninvasive means of detecting the presence of a tumor. Patients who have undergone initial treatment may only have small amounts of tumor DNA in their blood, which can be difficult to detect with conventional technology. TARDIS was developed to be highly sensitive and customizable for each patient, including those with only a trace amount of tumor remaining following surgery or other locali ....

Jeffreym Trent , Robert Stone , Kevin Conroy , Emily Henderson , Sciences Corp , Translational Genomics Research Institute Tgen , National Cancer , Translational Genomics Research Institute , National Comprehensive Cancer Network , Exact Science , Science Translational Medicine , Exact Sciences , Research Director , Translational Genomics Research , National Cancer Institute Designated , Cancer Diagnostics , ராபர்ட் ஸ்டோந் , கெவின் கான்ராய் , எமிலி ஹென்டர்சன் , அறிவியல் கார்ப் , தேசிய புற்றுநோய் , மொழிபெயர்ப்பு மரபியல் ஆராய்ச்சி நிறுவனம் , தேசிய விரிவான புற்றுநோய் வலைப்பின்னல் , சரியான அறிவியல் , அறிவியல் மொழிபெயர்ப்பு மருந்து , ஆராய்ச்சி இயக்குனர் ,